Hybrids & Chimeras
Inheritable Genetic Modification
Medical Gene Transfer
Sequencing & Genomics
Stem Cell Research
Patents & Other IP
A "Post-Human" Future?
Arts & Culture
Biopolitics, Parties & Pundits
Biotech & Pharma
Reproductive Justice, Health & Rights
Medical Gene Transfer : Displaying 86-95 of 142
Gene Therapy to Treat Cancer for First Time
Press Trust of India
June 19th, 2008
Doctors have treated a cancer patient by injecting him with billions of his own genetically-modified immune cells
Gene Fears by Doping Body
Edinburgh Evening News
June 12th, 2008
The World Anti-Doping Agency has called for increased awareness of the dangers of gene doping, which is thought to be the next big performance-enhancing threat in world sport.
Protecting research subjects from a broken system
by Marcy Darnovsky
April 8th, 2008
Until conflicts of interest are eliminated, research subjects will never be safe.
Eight Years after Jesse’s Death, Are Human Research Subjects Any Safer?
by Paul Gelsinger and Adil E. Shamoo
Hastings Center Report
April 4th, 2008
Many things stand in the way of better protection, but perhaps the greatest obstacle is the lack of adequate federal oversight.
The Future: Think performance enhancers are a problem now?
Welcome to the era of the genetically engineered superathlete
by David Epstein
March 11th, 2008
If athletes develop ways to alter their genes, the very blueprints for their own muscles, there may be no test of blood or urine that can pick that up.
Nature Biotech reports CGS skepticism about IRBs-for-hire
by Marcy Darnovsky
February 5th, 2008
An article published in Nature Biotech last September quotes CGS's Osagie Obasogie's concerns about private IRBs.
The New Republic Asks Whether Baseball is Already Losing the Next Doping Battle
by Osagie Obasogie
January 29th, 2008
The New Republic blog have shifted the focus of baseball's scrutiny from past to future by asking whether the sport is already losing the next big doping battle.
Boy gets leukaemia after gene treatment to cure ‘bubble baby syndrome’
The Times (UK)
December 19th, 2007
One of the first children in Britain to receive gene therapy for an immune system disorder has developed leukaemia as a result of his treatment.
Death in gene therapy trial raises questions about private IRBs
by Heidi Ledford
September 30th, 2007
Researchers are increasingly turning to private, for-profit IRBs that promise quick turnaround times, especially for company-sponsored trials.
More Public Accountability Needed in Gene Therapy Death, Says Public Interest Group
Center for Genetics and Society Calls for Moratorium on Enrolling Some Patients
September 17th, 2007
The Recombinant DNA Advisory Committee met today to discuss a recent death in an experiment, but offered no answers to important ethical questions raised by the tragedy.
Displaying 86-95 of 142
« First Page
Last Page »
« Show Complete List »
Why Gene Therapy Still Hasn't Produced Forecast Breakthroughs
In Utero Somatic Gene Transfer Proposals
Lawsuit in Gene Therapy Death Settled
The Hidden Costs of International Surrogacy
Breaking: New FDA Draft Guidance Views Fat Stem Cells As Drugs
Commercial DNA Testing May Cause Harm, Scientific Studies Show (If You Read Through to the Study Limitations at the End)
Commercialized Conception Casualties: "Brave" Baby Making?
CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 •
• (p) 1.510.665.7760 • (F) 1.510.665.8760